Acknowledged to be a Reference Drug
According to a letter of the Russian Ministry of Healthcare No 20-3/1262 of 19.09.2016 and letter of the Federal State Budgetary Institution NCESMP, Russian Ministry of Health No 13586 of 09.09.2016 “Mexidol®” (film-coated tablets, solution for intravenous and intramuscular administration) is acknowledged to be a reference drug.
It is of note, that MexidolÒ (the first ethylmethylhydroxypyridine succinate) was developed early in 1980-ies by State Institution Research Institute of Pharmacology RAMS.
The development was prepared by RAMS Academician A.V. Valdman and Pharmacologists L.D. Smirnov and V.I. Kuzmin were awarded government award for development and implementation into clinical practice”. The drug was widely acknowledged by healthcare community and patients. It received Russian Pharma Award in 2014 in the nomination Treatment of Choice for Ischaemic Disorders Caused by Cerebral Vasospasm.
It is only true that the drug showing itself to good advantage was acknowledged to be a reference drug in clinical practice.